BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 1246375)

  • 1. Progestational potency of oral contraceptives.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jan; 47(1):106-12. PubMed ID: 1246375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative potency of progestins used in oral contraceptives.
    Dorflinger LJ
    Contraception; 1985 Jun; 31(6):557-70. PubMed ID: 3899503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestational potency of oral contraceptives: a polemic.
    Edgren RA
    Int J Fertil; 1978; 23(3):162-9. PubMed ID: 40889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal contraception using estroprogestins].
    Grio R; Piacentino R; Cellura A; Caccuri D; Zaccheo F; Baccarini G; Marchino GL; Borgarino S; Fuda G
    Minerva Ginecol; 1990 Mar; 42(3):49-53. PubMed ID: 2187166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [After miniaturization to the limit, a double phase estro-progestin with early reinforcement. Result of a study of a new contraceptive based on d-norgestrel].
    Soutoul JH; Renaud M; Bertrand J
    Gynecologie; 1976; 27(5):487-93. PubMed ID: 1001603
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to paper by Dr. Edgren on "progestational potency of oral contraceptives: a polemic".
    Dickey RP
    Int J Fertil; 1978; 23(3):170-4. PubMed ID: 40890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Triquilar/Trinordiol. A new pill with 3 sequences].
    Obel EB
    Ugeskr Laeger; 1981 Jun; 143(25):1610-1. PubMed ID: 6795779
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of progestogens as postcoital oral contraceptives.
    Moggia A; Beauquis A; Ferrari F; Torrado ML; Alonso JL; Koremblit E; Mischler T
    J Reprod Med; 1974 Aug; 13(2):58-61. PubMed ID: 4844514
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevation of serum prolactin during application of oral contraceptives.
    Dericks-Tan JS; Taubert HD
    Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+.
    Dericks-Tan JS; Krög W; Aktories K; Taubert HD
    Contraception; 1976 Aug; 14(2):171-81. PubMed ID: 780050
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral contraceptives.
    Shearman RP
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine response to prostaglandin e2 under oral contraceptives.
    Toppozada M; Khowessah M; Shaala S; Said S; Osman M
    Contraception; 1976 Jun; 13(6):749-61. PubMed ID: 1277847
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the potency of orally administered progestins in women.
    King RJ; Whitehead MI
    Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency of progestogens in oral contraceptives--further delay of menses data.
    Swyer GI
    Contraception; 1982 Jul; 26(1):23-7. PubMed ID: 7128131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.